Emblem Corp. Completes $53.7 Million Bought Deal Offering

February 02, 2018

Emblem Corp. (“Emblem”), a Canadian licensed producer of medical cannabis, completed a bought deal public offering of units and convertible unsecured debentures for aggregate gross proceeds of approximately $53.7 million (the “Offering”). The Offering was completed with a syndicate of underwriters led by Eight Capital and including Canaccord Genuity Corp., Echelon Wealth Partners Inc. and GMP Securities L.P. (collectively, the “Underwriters”). 

Wildeboer Dellelce acted for the Underwriters in connection with the Offering with a team that included Perry Dellelce, Jeff Hergott, Danny Kharazmi and Amir Torabi (corporate/securities) and Katy Pitch (tax).